Skip to content

Effect of local anesthetic dose versus volume on block duration of single shot ultrasound-guided axillary brachial plexus block with mepivacaine.

Effect of local anesthetic dose versus volume on block duration of single shot ultrasound-guided axillary brachial plexus block with mepivacaine. - VolCon

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON37783
Enrollment
45
Registered
2012-05-21
Start date
2012-10-11
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

forearm wrist or hand orthopedic surgery

Interventions

Using a computer-generated sequence of random numbers and a sealed envelope technique, patients will be randomly allocated to receive single shot axillary brachial plexus block with either 30 mL mep

Sponsors

Sint Maartenskliniek
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patients of 18 years or older - ASA physical status classification I - III - Patients undergoing single shot axillary brachial plexus block for hand, wrist, or forearm orthopedic surgery - Written informed consent

Exclusion criteria

Exclusion criteria: - Contra-indications for regional anesthesia - Known hypersensitivity to amide-type local anesthetics - Known history of peripheral neuropathy - Any other reason which in the opinion of the investigator makes the patient unsuitable for participation in the study

Design outcomes

Primary

MeasureTime frame
Duration of sensory ABPB (overall and individual nerves).

Secondary

MeasureTime frame
Duration of motor block (overall and individual nerves) Onset of sensory and motor block (overall and individual nerves), Number of rescue blocks Time to first request for postoperative analgesia Satisfaction (NRS 0-10) with the anesthetic technique

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)